News | April 06, 2026
Samsung Biologics lands first US manufacturing facility with GSK acquisition
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
Safety was equally impressive. ENV-294 was well tolerated
He brings extensive cross-functional expertise built through leadership roles
Phase I to supply clean energy to five facilities, with long-term plans to power 19 hospitals through a 30 MW renewable network
The patient, suffering from calcific severe aortic stenosis—a dangerous narrowing of the heart valve caused by calcium buildup—had run out of standard treatment options
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
Company leadership is framing the move as transformational.
Subscribe To Our Newsletter & Stay Updated
